You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 11,617,751


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,617,751 protect, and when does it expire?

Patent 11,617,751 protects BEYAZ and SAFYRAL and is included in two NDAs.

Summary for Patent: 11,617,751
Title:Pharmaceutical composition containing a tetrahydrofolic acid
Abstract:The present invention relates to solid pharmaceutical compositions, in particular to oral contraceptives, comprising a progestogen, such as drospirenone; an estrogen, such as ethinylestradiol; a tetrahydrofolic acid or a pharmaceutically acceptable salt thereof, such as calcium 5-methyl-(6S)-tetrahydrofolate; and at least one pharmaceutical acceptable excipient or carrier. The compositions of the invention provide good stability of the tetrahydrofolic acid upon storage while still ensuring a fast and reliable release of the estrogen and the progestogen present in the composition.
Inventor(s):Kristina King
Assignee:Bayer Pharma AG, Bayer Intellectual Property GmbH
Application Number:US13/721,744
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,617,751

Introduction

Patents are a crucial component of intellectual property law, providing inventors and companies with exclusive rights to their innovations. The United States Patent 11,617,751, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it offers. Here, we will delve into the key aspects of this patent, including its claims, the patent landscape, and relevant legal and practical considerations.

Patent Overview

To begin with, it is essential to understand the basic structure of a patent. A patent typically includes several sections: the abstract, background of the invention, summary of the invention, detailed description of the invention, and the claims.

Claims Analysis

What are Patent Claims?

Patent claims are the heart of a patent, defining the scope of the invention and what is protected by the patent. They are the legal boundaries that distinguish the invention from prior art and other existing technologies[3].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim or another dependent claim.

Claim Construction

The interpretation of patent claims is critical in determining their scope and validity. Claim construction involves analyzing the language of the claims, the specification, and the prosecution history to understand what the inventor intended to claim. This process is often a point of contention in patent litigation, as seen in cases like Contour IP Holding LLC v. GoPro, Inc., where the court had to construe disputed claim terms to determine infringement[2].

Scope of Protection

Patent Eligibility

The scope of protection for any patent is also influenced by patent eligibility criteria. Under Section 101 of the Patent Act, inventions must be new and useful processes, machines, manufactures, or compositions of matter, or improvements thereof. However, certain exceptions apply, such as laws of nature, natural phenomena, and abstract ideas. The Alice test is a two-step framework used to determine if claims are directed to patent-ineligible subject matter[2].

Prior Art and Novelty

The scope of a patent is also defined by its novelty and non-obviousness over prior art. The patent must introduce something new and not obvious to a person of ordinary skill in the relevant field. This is a key consideration in the patent application process and in litigation, where prior art can be used to challenge the validity of a patent.

Patent Landscape

Trends in Patent Filings

The patent landscape is dynamic and influenced by various factors, including technological advancements and legal changes. For instance, the America Invents Act introduced the First Inventor to File provisions, which changed the way priority dates are determined for patent applications filed after March 16, 2013[1].

Economic and Innovation Impact

Patent data provide valuable insights into inventions and innovation trends. According to the National Science Foundation, patent data are crucial for understanding the inventions deemed valuable enough to patent, reflecting broader trends in R&D and innovation[4].

Legal and Practical Considerations

Filing and Prosecution

The process of filing and prosecuting a patent involves several steps, including the submission of the patent application, international search reports, and national phase entries. For international applications under the PCT, specific rules and timelines apply, such as the requirement to enter the national phase within 30 months from the priority date[1].

Litigation and Enforcement

Patent litigation is a significant aspect of the patent landscape. Cases like Contour IP Holding LLC v. GoPro, Inc. highlight the complexities involved in enforcing patent rights. The court's interpretation of claim terms and the application of legal tests such as the Alice test can significantly impact the outcome of patent disputes[2].

Small Claims Patent Court

There is ongoing discussion about the feasibility of a small claims patent court to address the high costs and complexities associated with patent litigation. Studies by the Administrative Conference of the United States (ACUS) have explored the need, structure, and potential impact of such a court, involving input from a wide range of stakeholders[5].

Examples and Case Studies

Contour IP Holding LLC v. GoPro, Inc.

This case illustrates the importance of claim construction and the application of patent eligibility tests. The court's decision to uphold the patentability of certain claims based on their specific technological improvements highlights the nuanced nature of patent law[2].

Statistics and Data

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset is invaluable for analyzing trends in patent scope and claims[3].

Key Takeaways

  • Claims Define Scope: Patent claims are the legal boundaries of an invention, distinguishing it from prior art.
  • Patent Eligibility: Inventions must meet specific criteria under Section 101 of the Patent Act, excluding abstract ideas and natural phenomena.
  • Prior Art and Novelty: Patents must be novel and non-obvious over prior art.
  • Dynamic Landscape: The patent landscape is influenced by technological advancements, legal changes, and economic factors.
  • Litigation and Enforcement: Patent litigation involves complex legal interpretations and can significantly impact the validity and enforceability of patents.

FAQs

What is the purpose of patent claims?

Patent claims define the scope of protection for an invention, distinguishing it from prior art and other existing technologies.

How are patent claims constructed?

Claim construction involves analyzing the language of the claims, the specification, and the prosecution history to understand what the inventor intended to claim.

What is the Alice test in patent law?

The Alice test is a two-step framework used to determine if claims are directed to patent-ineligible subject matter, such as abstract ideas.

Why is prior art important in patent law?

Prior art is crucial in determining the novelty and non-obviousness of an invention, which are essential for patent validity.

What is the role of the PCT in international patent filings?

The PCT (Patent Cooperation Treaty) allows for the filing of a single international patent application, which can then enter the national phase in multiple countries.

Sources

  1. PCT Applicant's Guide United States of America: WIPO, Valid as from 1 January 2023.
  2. CONTOUR IP HOLDING LLC v. GOPRO, INC.: United States Court of Appeals for the Federal Circuit, September 9, 2024.
  3. Patent Claims Research Dataset: USPTO, August 28, 2017.
  4. Chapter 8 - Invention, Knowledge Transfer, and Innovation: National Science Foundation, 2018.
  5. U.S. Patent Small Claims Court: Administrative Conference of the United States.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,617,751

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Bayer Hlthcare BEYAZ drospirenone; ethinyl estradiol; levomefolate calcium TABLET;ORAL 022532-001 Sep 24, 2010 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y PREVENTION OF PREGNANCY ⤷  Try for Free
Bayer Hlthcare BEYAZ drospirenone; ethinyl estradiol; levomefolate calcium TABLET;ORAL 022532-001 Sep 24, 2010 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y RAISE FOLATE LEVELS IN WOMEN WHO CHOOSE TO USE AN ORAL CONTRACEPTIVE AS THEIR METHOD OF CONTRACEPTION FOR THE PURPOSE OF REDUCING THE RISK OF A NEURAL TUBE DEFECT IN A PREGNANCY ⤷  Try for Free
Bayer Hlthcare BEYAZ drospirenone; ethinyl estradiol; levomefolate calcium TABLET;ORAL 022532-001 Sep 24, 2010 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y TREATMENT OF MODERATE ACNE VULGARIS IN WOMEN AT LEAST 14 YEARS OF AGE IF THE PATIENT DESIRES AN ORAL CONTRACEPTIVE FOR BIRTH CONTROL ⤷  Try for Free
Bayer Hlthcare BEYAZ drospirenone; ethinyl estradiol; levomefolate calcium TABLET;ORAL 022532-001 Sep 24, 2010 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y TREATMENT OF MOOD CHANGES AND/OR ANXIETY AS SYMPTOMS OF PREMENSTRUAL DYSPHORIC DISORDER (PMDD) IN WOMEN WHO CHOOSE TO USE AN ORAL CONTRACEPTIVE AS THEIR METHOD OF CONTRACEPTION ⤷  Try for Free
Bayer Hlthcare SAFYRAL drospirenone; ethinyl estradiol; levomefolate calcium TABLET;ORAL 022574-001 Dec 16, 2010 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y PREVENTION OF PREGNANCY ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.